vessel walls and atherosclerosis formation. Studies in animal models (Hayes & Khosla, 1992; Wolfe et al. 1993; Ahn et al. 1994) as well as in human subjects (Hegsted et al. 1965 (Hegsted et al. , 1993 Keys & Parlin, 1966; Mata et al. 1992) have shown that substituting dietary saturated by polyunsaturatedenriched oils resulted in a lowering of ApoA-I and HDL levels, indicating a possible deleterious effect of polyunsaturated fats. Therefore, in the process of evaluating the potential interest of a novel oil, it is necessary to assess its impact on HDL levels.
Transgenic animals expressing human Apo have proved to be fruitful models for the investigation of lipoprotein metabolism (Paigen et al. 1994; Breslow, 1996) . HuA-ITg mice are characterised by markedly increased levels of HDL (Walsh et al. 1989; Rubin et al. 1991a) . These properties confer protection against atherosclerosis to the cholesterolfed (Rubin et al. 1991b) or ApoE-de®cient HuA-ITg mice (Plump et al. 1994) . Thus, HuA-ITg mice appear to be a useful model to study the impact of nutritional manipulation on HDL metabolism.
The goal of the present study was to assess the effect of MPSO consumption on HDL levels in order to test whether the MPSO, like some other oils enriched in polyunsaturated fatty acids, also decreases HDL-cholesterol. Moreover, since reverse cholesterol transport is an important pathway that confers protection against atherosclerosis, the effect of a MPSO diet on cellular cholesterol ef¯ux was determined in vitro.
Methods

Animals
The studies were performed with HuA-ITg mice (Rubin et al. 1991a) . These mice were obtained in C57BL/6J background after multiple back-crosses (Transgenic Alliance, IFFA CREDO, L'Arbresle, France). Wild type C57BL/6J (WT) mice were used for control experiments. Before dietary studies all animals were acclimatised for 1 week under conditions of controlled temperature (20 6 18C) and lighting (dark from 20.00±08.00 hours) in a room of low background noise. The age of the mice was 5 months (SD 1 week).
Dietary experiments
Before each dietary experiment a blood sample was drawn for randomisation based on cholesterol levels. Mice were housed in cages (2±3 per cage) and were given free access to a fat-free semipuri®ed diet (UAR, Villemoisson sur Orge, France) supplemented with lard (Eurogat, Saint Denis, France) or MPSO (D'ANOSTE, Vendays-Montalivet, France) at 200 g/kg for 2 weeks (Table 1) . The other major nutrient components were (g/kg): carbohydrate 504, casein 180, cellulose 48, mineral mixture 56, vitamins 8. Weight gain was monitored throughout these studies. At the end of each dietary experiment, mice were food-deprived for 4 h and exsanguinated under diethyl ether anaesthesia by cardiac puncture. Experiment 1 was a three experimental factors design with ten mice per cell to compare the effect of MPSO and lard on lipid and lipoprotein variables in male and female WT and HuA-ITg mice. Experiment 2 was a three experimental factors design with three mice per cell to compare the effect of MPSO and lard on cellular cholesterol ef¯ux in male and female WT and HuA-ITg mice.
Lipid measurements
Blood was collected on EDTA or dry tubes for plasma (experiment 1) or serum (experiment 2) preparation respectively. Plasma and serum were separated by centrifugation (630 g) for 20 min at 48C. Lipids were determined enzymatically using commercially available kits for cholesterol (Cholesterol C System; Boehringer Mannheim, Mannheim, Germany), triacylglycerol (Triglycerides GPO-PAP; Boehringer Mannheim) and phospholipids (Phospholipids PAP 150; BioMe Ârieux, Lyon, France).
Gel-®ltration chromatography
Gel-®ltration chromatography was performed using a Superose 6 HR 10/30 column (Pharmacia, Pharmacia LKB Biotechnology, S-751 82 Uppsala, Sweden). The gel was allowed to equilibrate with PBS (10 mM) containing 0×1 g EDTA/l and 0×1 g sodium azide/l; 150 ml plasma were eluted with the buffer at room temperature at a¯ow rate of 0×02 ml/min. Elution pro®les were monitored at 280 nm and recorded with an analog-recorder chart tracing system (Pharmacia, Pharmacia LKB Biotechnology). The ef¯uents were collected in 0×24 ml fractions. Cholesterol and phospholipids were measured in each collected fraction using commercially available enzymatic kits (Cholesterol C System, Boehringer Mannheim; Phospholipids PAP 150, BioMe Ârieux).
Agarose-gel electrophoresis
Agarose-gel electrophoresis was performed according to Noble (Noble, 1968 ) with a Beckman Paragon system 354 G. Asset et al. 
High-density lipoprotein isolation and measurements
The fraction of serum 1×063 , d , 1×21 g/ml was separated by sequential ultracentrifugation using a Beckman TLA-100×4 rotor (Beckman Instruments France SA) at 480 000 g and 108C. Serum aliquots (100 ml) were adjusted to a density of 1×063 g/ml with potassium bromide and spun for 3 h. The supernatant fraction was discarded. Then, the infranatant fraction was adjusted to a density of 1×21 g/ml and spun twice for 3 h. The resulting serum fraction 1×063 , d , 1×21 g/ml was dialysed against a 10 mM-phosphate buffer containing 0×1 g EDTA/l and 0×1 g sodium azide/l. Lipids and proteins were determined enzymatically using commercially available kits for cholesterol (Cholesterol C System, Boehringer Mannheim), triacylglycerol (Triglycerides GPO-PAP; Boehringer Mannheim), phospholipids (Phospholipids PAP 150; BioMe Ârieux) and proteins (BCA protein assay reagent; Pierce, Rockford, IL, USA).
]cholesterol fractional ef¯ux was carried out essentially as previously described (de la Llera Moya et al. 1994) . Brie¯y, the ef¯ux potential of mice serum was assayed by incubating individual fresh unfrozen samples at 378C with the [ 3 H]cholesterol-labelled Fu5AH cells and then quantifying the amount of radio-labelled cellular cholesterol released to the acceptor-containing medium. Acceptors were extensively dialysed against Eagle's minimal essential medium. Serum specimens were used at a concentration of 5 % and cells were exposed to the acceptor serum for 4 h. At least three wells of cells were incubated with each sample. Samples were diluted into Eagle's minimal essential medium just before addition to cells. The labelled cell cholesterol released was measured in a portion of the medium by using standard liquid scintillation counting. The ef¯ux phase was ended by removing the serum-containing medium from each well. This ef¯ux medium was collected into tubes that had been chilled in an ice-bath and centrifuged at 48C for 5 min at 1000 g to remove anȳ oating cells. The cell-free medium was maintained at 08C until frozen at -708C for storage and further analysis. At the end of the ef¯ux period, cell monolayers were washed with PBS. The lipids were extracted by overnight incubation at room temperature with isopropanol, and cellular lipid radioactivity was measured in a portion of the extract. Fractional ef¯ux was calculated as the amount of the label released to the medium divided by the total label in each well. To standardise the cellular response obtained with different batches of cells and labelling medium, a human serum standard prepared from a pool was always included as a test serum. Although Fu5AH cells are rat hepatoma-derived cells this model has been validated and is widely used to assess serum-mediated cholesterol ef¯ux. The limits and advantages of this cellular model are extensively discussed in a previous paper (de la Llera Moya et al. 1994 ).
Statistical analysis
Three-way ANOVA was used to compare diet, sex and genotype effects. Whenever ANOVA was statistically signi®cant (P , 0×05), the Scheffe Â test was used for post hoc analysis. The SPSS Software release 7.5 for Windows was used (SPSS Institute Inc., Paris, France).
Results
Experiment 1
Lipid and lipoprotein. Three-way ANOVA showed no signi®cant interaction among any combination of factors and sex, i.e. sex´diet´genotype or sex´diet or sexǵ enotype, suggesting that male and female mice had a similar response to diet. There was, in contrast, a statistically signi®cant interaction between genotype and diet for cholesterol (P , 0×0001), phospholipids (P , 0×0001) and HDL-cholesterol (P , 0×003) indicating that HuA-ITg and WT mice had a different response to diet (Table 2) . Cholesterol, phospholipids or HDL-cholesterol levels were lower in both WT and HuA-ITg mice supplemented with MPSO than lard. Therefore, the interaction between genotype and diet was quantitative rather than qualitative. That is, the lipid and lipoprotein differences between the MPSO and the lard group were greater in HuA-ITg than WT mice. Finally, there was a statistically signi®cant main effect of diet for LDL-cholesterol (P , 0×01) and triacylglycerol (P , 0×05). MPSO-supplemented mice had lower levels of LDL-cholesterol and triacylglycerol than their respective lard-fed controls. The analyses of the electrophoretic properties of lipoproteins on agarose gel showed no major difference between diets.
High-density lipoprotein size. The cholesterol chromatography elution pro®le of WT mice indicated that the lowering of HDL upon MPSO treatment was similar across the HDL size range (Fig. 1) . In HuA-ITg mice the decrease in HDL-cholesterol ( Fig. 1 ) was more pronounced in the large HDL fractions than in the smaller fractions. Therefore, not only the levels but also the size distribution of HDL were affected in HuA-ITg mice with a shift toward smaller particles in the MPSO-treated animals. Similar results were obtained with measurement of phospholipids (data not shown).
Human apolipoprotein A-I in HuA-ITg mice. Two-way ANOVA indicated a statistically signi®cant interaction (P , 0×05) between sex and diet for human ApoA-I (Fig. 2) . Human ApoA-I levels (P , 0×0001) were lower in both male and female mice treated with MPSO than lard. The difference between dietary groups was more pronounced in males than in females suggesting a quantitative rather than a qualitative interaction.
Experiment 2
High-density lipoprotein composition. The lipid composition analysis of HDL revealed no major difference Mean values were signi®cantly different from those of the lard-fed group: *P , 0×05, **P , 0×01, ***P , 0×001 (post hoc analysis of maritime pine-seed oil v. lard). ² For details of diets and procedures see pp. 254±255 and Table 1 . ³ Three-way ANOVA was used to compare means, followed by Scheffe Â for post hoc analysis. Interaction and main effects terms are those of the ANOVA. § HDL-CHO and LDL-CHO were determined by gel-®ltration chromatography. between diets. In WT mice, cholesterol, phospholipids and protein contents were 19 %, 28 % and 53 % in lard-fed mice and 18 %, 29 % and 52 % in MPSO-fed mice. In HuA-ITg the values were 17 %, 33 % and 50 % and 16 %, 31 % and 53 % in the lard and MPSO group respectively. Triacylglycerol was not detected. In vitro cholesterol ef¯ux. Three-way ANOVA showed no signi®cant interaction among any combination of factors and sex or genotype i.e. sex´diet´genotype or sex´diet or gender´genotype or genotype´diet. There was a statistically signi®cant main effect of diet for serum freecholesterol (P , 0×0001), cholesterol esters (P , 0×002) and phospholipids (P , 0×002). These variables were lower in the MPSO-fed mice than in the lard-fed mice for both WT and HuA-ITg mice (Table 3) .
In respect of in vitro cholesterol ef¯ux, there was no evidence for a statistically signi®cant interaction among any combination of the three factors. There was, however, a statistically signi®cant main effect of sex (P , 0×008), genotype (P , 0×008) and diet (P , 0×05) on cholesterol ef¯ux (Fig. 3) . In vitro cholesterol ef¯ux was lower in females than in males, in WT than in HuA-ITg mice, and in the MPSO group than in the lard group. The ability of serum to promote in vitro cholesterol ef¯ux was correlated to serum phospholipids and to serum free or esteri®ed cholesterol levels (Fig. 4) . The slopes of the regression lines were different between mouse genotypes. For a given difference in serum phospholipids, free or esteri®ed cholesterol level between mice, in vitro cholesterol ef¯ux difference was smaller in the HuA-ITg mice than in the WT group.
Discussion
Maritime pine seeds are harvested in France on a multitonne-scale for reforestation. The oil extracted from the Table 1 . Values are mean for ten female and ten male mice per diet group with standard deviations represented by vertical bars. There was a statistically signi®cant interaction of sex´diet: P , 0×05 (two-way ANOVA). Mean values were signi®cantly different: ***P , 0×001 (post hoc analyses with the test of Scheffe Â ). Female  0×45  0×09  0×25  0×08  1×36  0×28  0×68  0×13  NS  0×0001  Male  0×60  0×08  0×38  0×14  1×82  0×40  0×92  0×40  Cholesterol esters  Female  2×28  0×13  1×54  0×13  4×31  1×25  2×53  0×58  NS  0×002  Male  2×83  0×11  1×54  0×98  5×04  0×81  3×49  1×43  Phospholipids  Female  2×19  0×16  1×68  0×12  4×50  0×59  3×06  0×41  NS  0×002  Male  3×12  0×26  2×11  1×06  6×79  0×78  4×38  1×65 Mean values were signi®cantly different from those of the lard-fed group: *P , 0×05, **P , 0×01, ***P , 0×001 (post hoc analysis of maritime pine-seed oil v. lard; no signi®cant differences were detected). ² For details of diets and procedures see pp. 254±255 and Table 1 . ³ Three-way ANOVA was used to compare means, followed by Scheffe Â for post hoc analysis. Interaction and main effects terms are those of the ANOVA. Table 1 . Values are means for three female or three male mice per diet group with standard deviations represented by vertical bars. There was a main effect of diet: P , 0×01 (three-way ANOVA).
seeds of this pine contains an average of 16 g D5 unsaturated polymethylene interrupted fatty acids/100 g fat, namely of all cis-5,9,12-18:3 and all cis-5,11,14-20:3 acids that differ in fatty acid composition from previously described pineseed oils (Wolff & Bayard, 1995) . MPSO decreases plasma triacylglycerol and VLDL-cholesterol levels in rats (Asset et al. 1999b ) indicating a potential interest in lipid-lowering therapy. The goal of the present study was to assess the impact of MPSO supplementation on HDL levels and cellular cholesterol ef¯ux. To this end, WT and HuA-ITg mice were given a diet containing 200 g lard or maritime pine oil/kg for 2 weeks. The results indicated that MPSO diet lowers HDLcholesterol levels and reduces the ability of mice serum to promote in vitro cholesterol ef¯ux as compared with lard. The latter effect was attenuated by overexpression of human ApoA-I. These data suggest that the decrease in HDL levels that is observed upon MPSO treatment might be less harmful in mice with elevated levels of ApoA-I.
HDL-cholesterol levels were lower in WT and HuA-ITg mice supplemented with MPSO than with lard suggesting an unfavourable effect of MPSO treatment on HDL metabolism. The mechanism by which MPSO lowers HDL is not known. Previous studies in rodents had shown that a polyunsaturated fatty acid-enriched diet was associated with low levels of HDL-cholesterol as compared with a more saturated-fat diet (Leach & Holub, 1984) . The reduction in HDL-cholesterol was attributed to either decreased production (Shepherd et al. 1978; Sorci-Thomas et al. 1989; Stucchi et al. 1991) or increased catabolic rates of ApoA-I (Brousseau et al. 1995b) depending on the experimental model, the type of diet and the metabolic variables that were measured (Stucchi et al. 1991) . In these studies, hepatic ApoA-I mRNA levels were either low (Sorci-Thomas et al. 1989; Kushwaha et al. 1991; Stucchi et al. 1991) or not affected (Sorci-Thomas et al. 1992; Ahn et al. 1994; Brousseau et al. 1995a, b) so that no clear mechanism of HDL-lowering has emerged from these investigations. The MPSO diet clearly resulted in lower HDL levels in WT mice and lower HDL and ApoA-I levels in HuA-ITg mice indicating an effect independent of genotype. This result is different from the effect of ®brate, a lipid-lowering agent, which decreases HDL-cholesterol levels in WT mice but increases HDL-cholesterol and human ApoA-I in HuA-ITg mice as well as in human subjects (Berthou et al. 1996) . Thus, if these observations can be extended to human physiology, these ®ndings would predict a detrimental effect of MPSO diet on HDL-cholesterol and ApoA-I levels in human subjects.
An important function of HDL is to transport cholesterol from peripheral tissues to the liver where the cholesterol is excreted in the intestinal tract. The ®rst step of reverse cholesterol transport involves ef¯ux of cholesterol from peripheral cells to HDL. This transport is essential for cholesterol homeostasis in peripheral tissues and for protection against atherosclerosis. The ability of mice serum to promote in vitro cholesterol ef¯ux was higher in HuA-ITg mice than in WT animals in agreement with an earlier investigation (Castro et al. 1997) . However, in vitro cholesterol ef¯ux was lower in both HuA-ITg and WT mice treated with MPSO than with lard indicating an effect independent of genotype. This ®nding is in agreement with previous observations which had shown a tendency (although not statistically signi®cant) towards lower levels of in vitro cholesterol ef¯ux in primates fed polyunsaturated-enriched oils instead of more saturated fats (Sola et al. 1993 ) suggesting a common effect of polyunsaturated fatty acid-enriched diets (Gillotte et al. 1998) . The mechanism by which MPSO diminishes in vitro cholesterol ef¯ux as compared with lard has not been investigated. However, the decrease in serum HDL levels certainly contributes to this effect. In rodents, HDL particles represent the vast majority of circulating lipoproteins. As in human subjects, HDL facilitate the movement of cholesterol from cultured cells to incubation media. Therefore, the lowering of HDL levels that is associated with MPSO diet as compared with lard certainly reduces the ability of serum to promote cholesterol ef¯ux in vitro. On the other hand, changes in HDL lipids fatty-acid length and degree of unsaturation affect the physico-chemical properties of HDL which in turn affect the ability of HDL to promote cellular cholesterol ef¯ux (Wassall et al. 1992) . Overall, feeding MPSO results in decreased HDL and ApoA-I levels as well as in reduced cholesterol ef¯ux indicating a potentially harmful effect of MPSO on the ®rst step of reverse cholesterol transport. This ®nding could explain the lack of protective effect of MPSO diet against atherosclerosis in ApoE-de®cient mice (Asset et al. 1999a) .
The ability of mice serum to promote in vitro cholesterol ef¯ux was correlated with its concentration in free or esteri®ed cholesterol and phospholipids. However, the relationship between serum lipids and in vitro cholesterol ef¯ux was different in HuA-ITg and WT mice. The slope of the regression line was less marked in the HuA-ITg than in the WT mice. Thus, for a given decrease in serum free or esteri®ed cholesterol or phospholipids levels between MPSO-and lard-fed mice the corresponding reduction in cholesterol ef¯ux was less pronounced in HuA-ITg mice than in WT animal. This indicates that overexpression of ApoA-I interferes with cholesterol ef¯ux in MPSO-fed mice and attenuates the detrimental effect of feeding a MPSO diet on cholesterol ef¯ux in vitro. In a tentative extrapolation of these results to human physiology, MPSO treatment could be used in patients with elevated triacylglycerol and HDLcholesterol levels. In this type of patient, the bene®t of reducing triacylglycerol would not be hampered by a major impact on reverse cholesterol transport.
In conclusion, the results of the present study demonstrate that MPSO supplementation is associated with lower levels of HDL in HuA-ITg and WT mice as compared with lard. In human subjects, the dietary substitution of saturated fatty acids by polyunsaturated fatty acids results in decreased levels of HDL and ApoA-I. This has led to recommendation of moderate consumption of polyunsaturated fatty acids in lipid-lowering diets. The results of the present study indicate that MPSO, like other polyunsaturated fatty acid-rich oils, also decreases ApoA-I and HDL levels, indicating a potentially undesirable effect of this oil on HDL metabolism. These data suggest that a careful analysis of the impact of MPSO on HDL metabolism is necessary in human subjects before recommending its use as dietary complement to lipid disorder treatments.
